<DOC>
	<DOCNO>NCT00796302</DOCNO>
	<brief_summary>This study determine safety effectiveness two medication treat aggression child attention deficit hyperactivity disorder ( ADHD ) .</brief_summary>
	<brief_title>Treatment Severe Childhood Aggression ( The TOSCA Study )</brief_title>
	<detailed_description>ADHD characterize inattention , impulsivity , hyperactivity . Children ADHD sometimes also disruptive behavior disorder ( DBDs ) , conduct disorder ( CD ) , estimate develop 20 % 40 % child ADHD , oppositional defiant disorder ( ODD ) , estimate develop 33 % 50 % child ADHD . These two disorder place youth risk psychiatric disorder , especially substance abuse disorder . Several medication test treat conduct disorder aggressive child , , among , risperidone methylphenidate hydrochloride ( HCl ) relatively good record safety tolerability . Psychostimulants , methylphenidate HCl , reduce symptom , , child DBDs . Combining methylphenidate HCl risperidone may one way increase effectiveness drug treatment . This study compare effectiveness methylphenidate HCl alone versus methylphenidate HCl combine risperidone treat aggressive behavior child ADHD . Participation study last 1 year . The child participant parent attend study visit . Two initial visit involve battery baseline test , include psychological clinical interview , physical examination , lab test , electrocardiogram ( ECG ) . The parent undergo parent education session complete questionnaires child 's behavior , emotion , medication side effect . The child vital sign measure complete test verbal memory attention impulsiveness . After second visit , child participant randomly assign receive either methylphenidate HCl alone methylphenidate HCl plus risperidone . For next 3 week , child participant take methylphenidate HCl dose start low gradually increase effective dose determine . For next 6 week , child participant add either risperidone placebo regimen methylphenidate HCl . This second medication also start low dose raise appropriate level tolerability . During 9 week medication adjustment , participant attend weekly study visit complete questionnaire vital sign measure . Parents attend education session visit . The child 's teacher also fill weekly questionnaire child 's behavior . Every 3 week , child participant test verbal memory , attention , impulsiveness . After 9-week period , child participant undergo physical exam , lab test , ECG . At point , child 's behavior improve , child continue treatment next 3 month . Monthly study visit include parent education session record parent teacher evaluation child . All participant attend 1-year follow-up visit include previous assessment .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>DSMIV diagnosis ADHD , subtype DSMIV diagnosis disruptive behavior disorder , include CD ODD Evidence serious physical aggression , rat Overt Aggression ScaleModified , determine parent guardian rating NCBRF DTotal Score . In addition , blind clinician must assign clinical global impression severity score 4 great aggression . Prior random assignment , participant must free psychotropic medicine 2 week drug ( antidepressant , alpha agonist , beta blocker , anxiolytic , mood stabilizer , antihistamine ) , 4 week depot antipsychotic fluoxetine . Fullscale IQ 71 Pregnancy history seizure disorder neurological medical disorder medication may present considerable risk Abnormal liver function Pervasive developmental disorder , schizophrenia psychotic disorder , eat disorder Currently take psychotropic medication discontinuation would present significant risk . Participants may discontinue satisfactory medication participate . Presence history major depressive disorder Diagnosis bipolar disorder A hypomanic/biphasic score 36 great rat child 's parent General Behavior Inventory confirm clinician indication mood disorder Active substance abuse disorder lack control substance use allow safe medication administration Evidence current child abuse neglect History suicide attempt past year current suicidal ideation plan and/or intent Family history type II diabetes two first degree relative , define biological parent and/or full biological sibling</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Conduct Disorder</keyword>
	<keyword>Attention Deficit Disruptive Behavior Disorders</keyword>
</DOC>